iCell Astrocytes (ASC-100-020-001-PT)
Product is covered by US Patent Nos. 5,527,701, 6,399,300, 8,148,148, 8,183,038, 8,252,586 and 8,440,461. Additional patents are pending.
iCell Cardiomyocytes (CMC-100-010-001, CMC-100-010-005, CMC-100-110-001, CMC-100-110-005)
US Patent Nos. 5,527,701, 5,733,727, 6,399,300, 8,183,038, 8,440,461, and corresponding foreign patent claims. Additional patents are pending.
iCell Endothelial Cells (ECC-100-010-001)
US Patent No. 8,183,038, 8,440,461 and corresponding foreign patent claims. Additional patents are pending.
iCell Neurons (NRC-100-010-001)
Product is covered by US Patent Nos. 5,527,701, 6,399,300, 8,148,148, 8,183,038, 8,252,586 and 8,440,461. Additional patents are pending.
iCell Hepatocytes (HCC-100-010-001)
US Patent Nos. 6,399,300, 7,510,876, 7,541,185, 7,625,753, 7,989,204, 8,008,075, 8,183,038, 8,440,461, and corresponding foreign patent claims. Additional patents are pending.
iCell Hematopoietic Progenitor Cells (HPC-301-020-001-PT)
Product is covered by US Patent Nos. 6,218,185, 7,105,343, 6,962,810, 7,892,830, 8,048,999, 8,183,038 and 8,268,620 and other patents pending.
MyCell Products (iPSC, iPSC-ENG, iPSC-CM, iPSC-NC, iPSC-EC, iPSC-HC, iPSC-CP)
US Patent Nos. 7,892,830, 8,048,999, 8,183,038, 8,268,620, and corresponding foreign patent claims. Additional patents are pending.
In addition, for MyCell Products that also involve the manufacture of differentiated cells, one or more of the patents associated with the particular cell type listed above may also be applicable.
